Compare ELAN & ONTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELAN | ONTO |
|---|---|---|
| Founded | 1954 | 1940 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 10.9B |
| IPO Year | 2018 | N/A |
| Metric | ELAN | ONTO |
|---|---|---|
| Price | $25.18 | $217.27 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 8 |
| Target Price | $24.44 | ★ $183.75 |
| AVG Volume (30 Days) | ★ 4.7M | 906.7K |
| Earning Date | 02-24-2026 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.07 | ★ 3.55 |
| Revenue | ★ $4,591,000,000.00 | $1,002,336,000.00 |
| Revenue This Year | $7.25 | $3.82 |
| Revenue Next Year | $5.80 | $18.15 |
| P/E Ratio | $350.10 | ★ $60.47 |
| Revenue Growth | 3.08 | ★ 6.38 |
| 52 Week Low | $8.02 | $85.88 |
| 52 Week High | $26.08 | $229.87 |
| Indicator | ELAN | ONTO |
|---|---|---|
| Relative Strength Index (RSI) | 58.50 | 62.49 |
| Support Level | $24.76 | $213.01 |
| Resistance Level | $26.08 | $229.87 |
| Average True Range (ATR) | 0.71 | 11.38 |
| MACD | 0.01 | -0.16 |
| Stochastic Oscillator | 62.36 | 78.27 |
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the sources of total revenue.